Antonio Drago

1976 -

country of citizenship: Italy

languages spoken, written or signed: Italian, English

occupation: psychobiologist, psychiatrist, researcher

Series

There is nothing here

Create a new serie

Works

There is nothing here

Create a new work

Articles 56

Date

Title

Authors

2019-11-14

Molecular pathway analysis associates alterations in obesity-related genes and antipsychotic-induced weight gain

Henrik Thyge Corfitsen, Agnete Larsen, Antonio Drago
2017-05-05

A molecular pathway analysis stresses the role of inflammation and oxidative stress towards cognition in schizophrenia

Antonio Drago
2017-10-23

A molecular pathway analysis informs the genetic risk for arrhythmias during antipsychotic treatment.

Antonio Drago
2016-06-13

Videoconferencing in psychiatry, a meta-analysis of assessment and treatment

Antonio Drago, Trine Nøhr Winding, Niki Antypa
2016-11-27

Insight gained from genome-wide interaction and enrichment analysis on weight gain during citalopram treatment

Henrik Thyge Corfitsen, Antonio Drago
2015-01-12

CRY1 Variations Impacts on the Depressive Relapse Rate in a Sample of Bipolar Patients

Barbara Monti, Antonio Drago, Alessandro Serretti
2015-06-26

Genes involved in pruning and inflammation are enriched in a large mega-sample of patients affected by Schizophrenia and Bipolar Disorder and controls

Antonio Drago
2015-04-24

Hippocampal Pruning as a New Theory of Schizophrenia Etiopathogenesis

Enrico Cocchi, Antonio Drago, Alessandro Serretti
2015-10-23

The microtubule-associated molecular pathways may be genetically disrupted in patients with Bipolar Disorder. Insights from the molecular cascades

Antonio Drago, Alessandro Serretti
2015-03-26

Enrichment pathway analysis. The inflammatory genetic background in Bipolar Disorder

Antonio Drago
2014-02-27

Genetic variations within metalloproteinases impact on the prophylaxis of depressive phases in bipolar patients

Barbara Monti, Antonio Drago, Alessandro Serretti
2014-11-29

A model to investigate SNPs' interaction in GWAS studies

Enrico Cocchi, Chiara Fabbri, Antonio Drago, Alessandro Serretti
2014-12-30

A molecular pathway analysis informs the genetic background at risk for schizophrenia

Antonio Drago, Alessandro Serretti, Edoardo Spina
2014-07-05

DISC1-TSNAX and DAOA genes in major depression and citalopram efficacy.

Chiara Fabbri, Antonio Drago, Marina Mitjans, Alessandro Serretti
2014-07-02

A molecular pathway analysis of the glutamatergic-monoaminergic interplay serves to investigate the number of depressive records during citalopram treatment.

Antonio Drago, Enrico Cocchi, Alessandro Serretti
2014-06-01

Genome-wide association study supports the role of the immunological system and of the neurodevelopmental processes in response to haloperidol treatment.

Antonio Drago, Alessandro Serretti, Ina Giegling, Dan Rujescu, Annette M Hartmann, Marion Friedl, Bettina Konte
2014-04-08

PPP3CC gene: a putative modulator of antidepressant response through the B-cell receptor signaling pathway

Chiara Fabbri, Diego Albani, Raffaella Calati, Antonio Drago, Antonio Drago, Siegfried Kasper, Rupert Lanzenberger, Alessandro Serretti
2013-06-18

The role of COMT gene variants in depression: Bridging neuropsychological, behavioral and clinical phenotypes

Niki Antypa, Antonio Drago, Alessandro Serretti
2013-12-10

The genetics of vascular incidents associated with second-generation antipsychotic administration

Enrico Cocchi, Antonio Drago, Alessandro Serretti
2013-07-01

Genomewide interaction and enrichment analysis on antidepressant response

Niki Antypa, Antonio Drago
2012-10-15

No association of a set of candidate genes on haloperidol side effects

Antonio Drago, Alessandro Serretti, Hans-Jürgen Möller, Ina Giegling, Dan Rujescu, Annette M Hartmann, Diana De Ronchi, Hans H Stassen
2012-08-11

Early antidepressant efficacy modulation by glutamatergic gene variants in the STAR*D.

Chiara Fabbri, Antonio Drago, Alessandro Serretti
2012-09-11

AKAP13, CACNA1, GRIK4 and GRIA1 genetic variations may be associated with haloperidol efficacy during acute treatment.

Antonio Drago, Alessandro Serretti, Hans-Jürgen Möller, Ina Giegling, Dan Rujescu, Annette M Hartmann, Marion Friedl, Bettina Konte, Diana De Ronchi, Hans H Stassen
2011-03-01

Pharmacogenetics of antidepressant response.

Raffaella Calati, Stefano Porcelli, Chiara Fabbri, Antonio Drago, Alessandro Serretti
2011-02-16

Pharmacogenetics of antidepressants

Stefano Porcelli, Chiara Fabbri, Antonio Drago, Alessandro Serretti, Edoardo Spina
2011-03-11

Mechanisms of antidepressant action: an integrated dopaminergic perspective

Stefano Porcelli, Chiara Fabbri, Antonio Drago
2011-06-21

The molecular interaction between the glutamatergic, noradrenergic, dopaminergic and serotoninergic systems informs a detailed genetic perspective on depressive phenotypes

Antonio Drago, Alessandro Serretti
2011-10-11

The genetics of antipsychotic induced tremors: a genome-wide pathway analysis on the STEP-BD SCP sample

Antonio Drago, Alessandro Serretti
2011-06-01

Sociodemographic features predict antidepressant trajectories of response in diverse antidepressant pharmacotreatment environments: a comparison between the STAR*D study and an independent trial.

Antonio Drago, Alessandro Serretti
2011-04-01

Glutamatergic gene variants impact the clinical profile of efficacy and side effects of haloperidol

Antonio Drago, Alessandro Serretti, Hans-Jürgen Möller
2010-05-07

Pharmacogenetics of lithium long-term treatment: focus on initiation and adaptation mechanisms

Antonio Drago, Alessandro Serretti
2010-09-21

Specificity profile of paroxetine in major depressive disorder: meta-regression of double-blind, randomized clinical trials

Antonio Drago, Alessandro Serretti

Human - wd:Q47812506

Welcome to Inventaire

the library of your friends and communities

learn more